{
  "company_number": "09395037",
  "name": "Caithness Biotechnologies Limited",
  "url": "/company/09395037",
  "status": "Active",
  "is_active": true,
  "company_type": "Private Limited Company",
  "incorporated_on": "2015-01-19",
  "dissolved_on": null,
  "sic_codes": [
    {
      "code": "21100",
      "description": "Manufacture of basic pharmaceutical products",
      "section": "C",
      "section_name": "Manufacturing",
      "url": "/sic/21100"
    }
  ],
  "registered_address": {
    "id": 1073076,
    "url": "/address/1073076",
    "line1": "72 BOSTON ROAD",
    "line2": "",
    "post_town": "LEICESTER",
    "county": "",
    "country": "ENGLAND",
    "postcode": "LE4 1HB"
  },
  "companies_house_url": "https://find-and-update.company-information.service.gov.uk/company/09395037",
  "previous_names": [],
  "care_of": "",
  "po_box": "",
  "country_of_origin": "United Kingdom",
  "accounts": {
    "next_due": "2026-10-31",
    "last_made_up": "2025-01-31",
    "category": "TOTAL EXEMPTION FULL",
    "filings": [
      {
        "url": "/company/09395037/accounts/2025-01-31",
        "pdf_url": "/company/09395037/accounts/2025-01-31.pdf",
        "made_up_date": "2025-01-31",
        "period_start": "2025-01-31",
        "period_end": "2025-01-31",
        "entity_name": "Caithness Biotechnologies Limited",
        "dormant": false,
        "average_employees": "1.00",
        "tangible_fixed_assets": "5681.00",
        "debtors": "4291.00",
        "cash_bank_in_hand": "2487.00",
        "current_assets": "10303.00",
        "creditors_due_within_one_year": null,
        "creditors_due_after_one_year": null,
        "net_current_assets_liabilities": "-10108.00",
        "total_assets_less_current_liabilities": "-4427.00",
        "net_assets_liabilities": "-4427.00",
        "called_up_share_capital": "1.00",
        "profit_loss_account_reserve": "-4428.00",
        "shareholder_funds": "1.00",
        "turnover": null,
        "other_operating_income": null,
        "cost_sales": null,
        "gross_profit_loss": null,
        "administrative_expenses": null,
        "raw_materials_consumables": null,
        "staff_costs": null,
        "depreciation_written_off": null,
        "other_operating_charges": null,
        "operating_profit_loss": null,
        "profit_before_tax": null,
        "tax_on_profit": null,
        "profit_loss_for_period": null,
        "file_type": "html",
        "parse_error": "",
        "source_zip": "Accounts_Monthly_Data-September2025.zip"
      },
      {
        "url": "/company/09395037/accounts/2024-01-31",
        "pdf_url": "/company/09395037/accounts/2024-01-31.pdf",
        "made_up_date": "2024-01-31",
        "period_start": "2024-01-31",
        "period_end": "2024-01-31",
        "entity_name": "Caithness Biotechnologies Limited",
        "dormant": false,
        "average_employees": "1.00",
        "tangible_fixed_assets": "6683.00",
        "debtors": "354.00",
        "cash_bank_in_hand": "4900.00",
        "current_assets": "8754.00",
        "creditors_due_within_one_year": null,
        "creditors_due_after_one_year": null,
        "net_current_assets_liabilities": "-6413.00",
        "total_assets_less_current_liabilities": "270.00",
        "net_assets_liabilities": "270.00",
        "called_up_share_capital": "1.00",
        "profit_loss_account_reserve": "269.00",
        "shareholder_funds": "1.00",
        "turnover": null,
        "other_operating_income": null,
        "cost_sales": null,
        "gross_profit_loss": null,
        "administrative_expenses": null,
        "raw_materials_consumables": null,
        "staff_costs": null,
        "depreciation_written_off": null,
        "other_operating_charges": null,
        "operating_profit_loss": null,
        "profit_before_tax": null,
        "tax_on_profit": null,
        "profit_loss_for_period": null,
        "file_type": "html",
        "parse_error": "",
        "source_zip": "Accounts_Monthly_Data-September2024.zip"
      },
      {
        "url": "/company/09395037/accounts/2023-01-31",
        "pdf_url": "/company/09395037/accounts/2023-01-31.pdf",
        "made_up_date": "2023-01-31",
        "period_start": "2023-01-31",
        "period_end": "2023-01-31",
        "entity_name": "Caithness Biotechnologies Limited",
        "dormant": false,
        "average_employees": "1.00",
        "tangible_fixed_assets": "1922.00",
        "debtors": "2027.00",
        "cash_bank_in_hand": "9805.00",
        "current_assets": "15582.00",
        "creditors_due_within_one_year": null,
        "creditors_due_after_one_year": null,
        "net_current_assets_liabilities": "3094.00",
        "total_assets_less_current_liabilities": "5016.00",
        "net_assets_liabilities": "5016.00",
        "called_up_share_capital": "1.00",
        "profit_loss_account_reserve": "5015.00",
        "shareholder_funds": "1.00",
        "turnover": null,
        "other_operating_income": null,
        "cost_sales": null,
        "gross_profit_loss": null,
        "administrative_expenses": null,
        "raw_materials_consumables": null,
        "staff_costs": null,
        "depreciation_written_off": null,
        "other_operating_charges": null,
        "operating_profit_loss": null,
        "profit_before_tax": null,
        "tax_on_profit": null,
        "profit_loss_for_period": null,
        "file_type": "html",
        "parse_error": "",
        "source_zip": "Accounts_Monthly_Data-August2023.zip"
      },
      {
        "url": "/company/09395037/accounts/2022-01-31",
        "pdf_url": "/company/09395037/accounts/2022-01-31.pdf",
        "made_up_date": "2022-01-31",
        "period_start": "2022-01-31",
        "period_end": "2022-01-31",
        "entity_name": "Caithness Biotechnologies Limited",
        "dormant": false,
        "average_employees": "1.00",
        "tangible_fixed_assets": "2262.00",
        "debtors": "992.00",
        "cash_bank_in_hand": "10864.00",
        "current_assets": "16056.00",
        "creditors_due_within_one_year": null,
        "creditors_due_after_one_year": null,
        "net_current_assets_liabilities": "3851.00",
        "total_assets_less_current_liabilities": "6113.00",
        "net_assets_liabilities": "6113.00",
        "called_up_share_capital": "1.00",
        "profit_loss_account_reserve": "6112.00",
        "shareholder_funds": "1.00",
        "turnover": null,
        "other_operating_income": null,
        "cost_sales": null,
        "gross_profit_loss": null,
        "administrative_expenses": null,
        "raw_materials_consumables": null,
        "staff_costs": null,
        "depreciation_written_off": null,
        "other_operating_charges": null,
        "operating_profit_loss": null,
        "profit_before_tax": null,
        "tax_on_profit": null,
        "profit_loss_for_period": null,
        "file_type": "html",
        "parse_error": "",
        "source_zip": "Accounts_Monthly_Data-October2022.zip"
      },
      {
        "url": "/company/09395037/accounts/2021-01-31",
        "pdf_url": "/company/09395037/accounts/2021-01-31.pdf",
        "made_up_date": "2021-01-31",
        "period_start": "2021-01-31",
        "period_end": "2021-01-31",
        "entity_name": "Caithness Biotechnologies Limited",
        "dormant": false,
        "average_employees": "1.00",
        "tangible_fixed_assets": "2445.00",
        "debtors": "6568.00",
        "cash_bank_in_hand": "13163.00",
        "current_assets": "21731.00",
        "creditors_due_within_one_year": null,
        "creditors_due_after_one_year": null,
        "net_current_assets_liabilities": "8343.00",
        "total_assets_less_current_liabilities": "10788.00",
        "net_assets_liabilities": "10788.00",
        "called_up_share_capital": "1.00",
        "profit_loss_account_reserve": "10787.00",
        "shareholder_funds": "1.00",
        "turnover": null,
        "other_operating_income": null,
        "cost_sales": null,
        "gross_profit_loss": null,
        "administrative_expenses": null,
        "raw_materials_consumables": null,
        "staff_costs": null,
        "depreciation_written_off": null,
        "other_operating_charges": null,
        "operating_profit_loss": null,
        "profit_before_tax": null,
        "tax_on_profit": null,
        "profit_loss_for_period": null,
        "file_type": "html",
        "parse_error": "",
        "source_zip": "Accounts_Monthly_Data-October2021.zip"
      },
      {
        "url": "/company/09395037/accounts/2020-01-31",
        "pdf_url": "/company/09395037/accounts/2020-01-31.pdf",
        "made_up_date": "2020-01-31",
        "period_start": "2020-01-31",
        "period_end": "2020-01-31",
        "entity_name": "Caithness Biotechnologies Limited",
        "dormant": false,
        "average_employees": "1.00",
        "tangible_fixed_assets": "2432.00",
        "debtors": "3944.00",
        "cash_bank_in_hand": "10164.00",
        "current_assets": "20608.00",
        "creditors_due_within_one_year": null,
        "creditors_due_after_one_year": null,
        "net_current_assets_liabilities": "6356.00",
        "total_assets_less_current_liabilities": "8788.00",
        "net_assets_liabilities": null,
        "called_up_share_capital": null,
        "profit_loss_account_reserve": null,
        "shareholder_funds": "1.00",
        "turnover": null,
        "other_operating_income": null,
        "cost_sales": null,
        "gross_profit_loss": null,
        "administrative_expenses": null,
        "raw_materials_consumables": null,
        "staff_costs": null,
        "depreciation_written_off": null,
        "other_operating_charges": null,
        "operating_profit_loss": null,
        "profit_before_tax": null,
        "tax_on_profit": null,
        "profit_loss_for_period": null,
        "file_type": "html",
        "parse_error": "",
        "source_zip": "Accounts_Monthly_Data-October2020.zip"
      },
      {
        "url": "/company/09395037/accounts/2019-01-31",
        "pdf_url": "/company/09395037/accounts/2019-01-31.pdf",
        "made_up_date": "2019-01-31",
        "period_start": "2019-01-31",
        "period_end": "2019-01-31",
        "entity_name": "Caithness Biotechnologies Limited",
        "dormant": false,
        "average_employees": "1.00",
        "tangible_fixed_assets": "1710.00",
        "debtors": "3053.00",
        "cash_bank_in_hand": "529.00",
        "current_assets": "10082.00",
        "creditors_due_within_one_year": null,
        "creditors_due_after_one_year": null,
        "net_current_assets_liabilities": "-5905.00",
        "total_assets_less_current_liabilities": "-4195.00",
        "net_assets_liabilities": null,
        "called_up_share_capital": null,
        "profit_loss_account_reserve": null,
        "shareholder_funds": "1.00",
        "turnover": null,
        "other_operating_income": null,
        "cost_sales": null,
        "gross_profit_loss": null,
        "administrative_expenses": null,
        "raw_materials_consumables": null,
        "staff_costs": null,
        "depreciation_written_off": null,
        "other_operating_charges": null,
        "operating_profit_loss": null,
        "profit_before_tax": null,
        "tax_on_profit": null,
        "profit_loss_for_period": null,
        "file_type": "html",
        "parse_error": "",
        "source_zip": "Accounts_Monthly_Data-October2019.zip"
      },
      {
        "url": "/company/09395037/accounts/2018-01-31",
        "pdf_url": "/company/09395037/accounts/2018-01-31.pdf",
        "made_up_date": "2018-01-31",
        "period_start": "2018-01-31",
        "period_end": "2018-01-31",
        "entity_name": "Caithness Biotechnologies Limited",
        "dormant": false,
        "average_employees": "1.00",
        "tangible_fixed_assets": "2012.00",
        "debtors": "1982.00",
        "cash_bank_in_hand": "1377.00",
        "current_assets": "10006.00",
        "creditors_due_within_one_year": null,
        "creditors_due_after_one_year": null,
        "net_current_assets_liabilities": "-2560.00",
        "total_assets_less_current_liabilities": "-548.00",
        "net_assets_liabilities": null,
        "called_up_share_capital": null,
        "profit_loss_account_reserve": null,
        "shareholder_funds": "1.00",
        "turnover": null,
        "other_operating_income": null,
        "cost_sales": null,
        "gross_profit_loss": null,
        "administrative_expenses": null,
        "raw_materials_consumables": null,
        "staff_costs": null,
        "depreciation_written_off": null,
        "other_operating_charges": null,
        "operating_profit_loss": null,
        "profit_before_tax": null,
        "tax_on_profit": null,
        "profit_loss_for_period": null,
        "file_type": "html",
        "parse_error": "",
        "source_zip": "Accounts_Monthly_Data-October2018.zip"
      },
      {
        "url": "/company/09395037/accounts/2017-01-31",
        "pdf_url": "/company/09395037/accounts/2017-01-31.pdf",
        "made_up_date": "2017-01-31",
        "period_start": "2017-01-31",
        "period_end": "2017-01-31",
        "entity_name": "Caithness Biotechnologies Limited",
        "dormant": false,
        "average_employees": "1.00",
        "tangible_fixed_assets": "2191.00",
        "debtors": "5780.00",
        "cash_bank_in_hand": "503.00",
        "current_assets": "10936.00",
        "creditors_due_within_one_year": null,
        "creditors_due_after_one_year": null,
        "net_current_assets_liabilities": "-3181.00",
        "total_assets_less_current_liabilities": "-990.00",
        "net_assets_liabilities": null,
        "called_up_share_capital": null,
        "profit_loss_account_reserve": null,
        "shareholder_funds": "1.00",
        "turnover": null,
        "other_operating_income": null,
        "cost_sales": null,
        "gross_profit_loss": null,
        "administrative_expenses": null,
        "raw_materials_consumables": null,
        "staff_costs": null,
        "depreciation_written_off": null,
        "other_operating_charges": null,
        "operating_profit_loss": null,
        "profit_before_tax": null,
        "tax_on_profit": null,
        "profit_loss_for_period": null,
        "file_type": "html",
        "parse_error": "",
        "source_zip": "Accounts_Monthly_Data-October2017.zip"
      },
      {
        "url": "/company/09395037/accounts/2016-01-31",
        "pdf_url": "/company/09395037/accounts/2016-01-31.pdf",
        "made_up_date": "2016-01-31",
        "period_start": "2016-01-31",
        "period_end": "2016-01-31",
        "entity_name": "Caithness Biotechnologies Limited",
        "dormant": false,
        "average_employees": null,
        "tangible_fixed_assets": "2397.00",
        "debtors": null,
        "cash_bank_in_hand": "2711.00",
        "current_assets": "6552.00",
        "creditors_due_within_one_year": "14266.00",
        "creditors_due_after_one_year": null,
        "net_current_assets_liabilities": "-7714.00",
        "total_assets_less_current_liabilities": "-5317.00",
        "net_assets_liabilities": null,
        "called_up_share_capital": "1.00",
        "profit_loss_account_reserve": "-5318.00",
        "shareholder_funds": "-5317.00",
        "turnover": null,
        "other_operating_income": null,
        "cost_sales": null,
        "gross_profit_loss": null,
        "administrative_expenses": null,
        "raw_materials_consumables": null,
        "staff_costs": null,
        "depreciation_written_off": null,
        "other_operating_charges": null,
        "operating_profit_loss": null,
        "profit_before_tax": null,
        "tax_on_profit": null,
        "profit_loss_for_period": null,
        "file_type": "html",
        "parse_error": "",
        "source_zip": "Accounts_Monthly_Data-October2016.zip"
      }
    ],
    "pdf_only_filings": [],
    "filing_history_url": "https://find-and-update.company-information.service.gov.uk/company/09395037/filing-history"
  },
  "confirmation_statement": {
    "next_due": "2027-02-02",
    "last_made_up": "2026-01-19"
  },
  "officers": [],
  "psc": [
    {
      "name": "Dr Clett Erridge",
      "kind": "individual-person-with-significant-control",
      "person_url": "/person/982346",
      "controlling_company_url": null,
      "natures_of_control": [
        "ownership-of-shares-75-to-100-percent"
      ],
      "notified_on": "2016-04-06",
      "ceased_on": null,
      "nationality": "British",
      "country_of_residence": "England",
      "source": "snapshot"
    }
  ],
  "external_links": [],
  "provenance": {
    "source": "snapshot",
    "first_seen_at": "2026-07-05T12:35:35.811816+00:00",
    "last_seen_snapshot": "2026-08-01",
    "retrieved_at": "2026-08-14T22:50:00.959197+00:00"
  },
  "licence": "Open Government Licence v3.0",
  "licence_url": "https://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/",
  "attribution": "Contains public sector information licensed under the Open Government Licence v3.0. Source: Companies House."
}